Evidence map›Paper›PMID 25847130›Full record

ArticleXenotransplantation

Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.

Laura Higginbotham, Dave Mathews, Cynthia A Breeden, Mingqing Song, Alton Brad Farris, Christian P Larsen, Mandy L Ford, Andrew J Lutz, Matthew Tector, Kenneth A Newell and 2 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
26.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 216 citations in OpenAlex.

  1. Trial
  2. Review
  3. A novel immunoglobulin G- and immunoglobulin cleaving enzyme MG (IceMG), for antibody-mediated rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  4. Article
  5. Complement activation in kidney transplantation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Immunometabolism of Liver Xenotransplantation and Prospective Solutions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Article
  11. Progress in Porcine Kidney Transplantation to Non-Human Primates.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  12. Article
  13. Article
  14. Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. The Evolution of Immunosuppressive Therapy in Pig-to-Nonhuman Primate Organ Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  19. Article
  20. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Laura HigginbothamDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Dave MathewsDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Cynthia A BreedenDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Mingqing SongDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Alton Brad FarrisAnatomic Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Christian P LarsenDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Mandy L FordDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Andrew J LutzDepartment of Surgery, Indiana University Health Transplant Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Matthew TectorIndiana University Health Transplant Department, Indianapolis, IN, USA.
Kenneth A NewellDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
A Joseph TectorDepartment of Surgery, Indiana University Health Transplant Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Andrew B AdamsDepartment of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Emory University · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI WALLEN, KIM · 1985 to 2011
$114.0M
Transplant Tolerance in Non-Human PrimatesU19AI051731 · NIAID · UNIVERSITY OF WESTERN ONTARIO · PI ADAMS, ANDREW B · 2002 to 2022
$54.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Advanced Research Training in Transplantation ScienceT32AI070081 · NIAID · EMORY UNIVERSITY · PI Mandy L Ford · 2006 to 2026
$3.1M
Novel Combined Costimulation and CD122 Blockade in Islet TransplantationF30DK109665 · NIDDK · EMORY UNIVERSITY · PI MATHEWS, DAVID · 2016 to 2018
$146k
NCRR NIH HHS P51 RR000165NCRR NIH HHS RR00165NIAID NIH HHS T32 AI070081NIAID NIH HHS U19 AI051731NIDDK NIH HHS F30 DK109665NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

Xenotransplantation has the potential to alleviate the organ shortage that prevents many patients with end-stage renal disease from enjoying the benefits of kidney transplantation. Despite significant advances in other models, pig-to-primate kidney xenotransplantation has met limited success. Preformed anti-pig antibodies are an important component of the xenogeneic immune response. To address this, we screened a cohort of 34 rhesus macaques for anti-pig antibody levels. We then selected animals with both low and high titers of anti-pig antibodies to proceed with kidney transplant from galactose-α1,3-galactose knockout/CD55 transgenic pig donors. All animals received T-cell depletion followed by maintenance therapy with costimulation blockade (either anti-CD154 mAb or belatacept), mycophenolate mofetil, and steroid. The animal with the high titer of anti-pig antibody rejected the kidney xenograft within the first week. Low-titer animals treated with anti-CD154 antibody, but not belatacept exhibited prolonged kidney xenograft survival (>133 and >126 vs. 14 and 21 days, respectively). Long-term surviving animals treated with the anti-CD154-based regimen continue to have normal kidney function and preserved renal architecture without evidence of rejection on biopsies sampled at day 100. This description of the longest reported survival of pig-to-non-human primate kidney xenotransplantation, now >125 days, provides promise for further study and potential clinical translation.

Indexed as

Kidney TransplantationTransplantation, HeterologousAnimalsAnimals, Genetically ModifiedCD40 LigandGraft RejectionGraft SurvivalHeterograftsImmunosuppressive AgentsKidneyMacaca mulattaSwineCD40 LigandImmunosuppressive Agentscostimulation blockadehuman decay-accelerating factornon-human primaterenal transplantationtransgenic pigsxenoantigenxenotransplantationα-1,3-galactosyltransferase

Identifiers

PMID25847130
PMCPMC4930152
OpenAlexW2068128688

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.